4BG1
Three dimensional structure of human gamma-butyrobetaine hydroxylase in complex with 1-(3-Carboxypropyl)-1-methylpyrrolidin-1-ium chloride
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | MAX II BEAMLINE I911-3 |
Synchrotron site | MAX II |
Beamline | I911-3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-11-11 |
Detector | MARRESEARCH |
Spacegroup name | H 3 2 |
Unit cell lengths | 107.630, 107.630, 205.530 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 26.920 - 1.890 |
R-factor | 0.15808 |
Rwork | 0.156 |
R-free | 0.19906 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3o2g |
RMSD bond length | 0.010 |
RMSD bond angle | 1.389 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 26.910 | 1.980 |
High resolution limit [Å] | 1.880 | 1.880 |
Rmerge | 0.080 | 0.560 |
Number of reflections | 37202 | |
<I/σ(I)> | 9.1 | 1.9 |
Completeness [%] | 97.3 | 81.9 |
Redundancy | 3.1 | 2.8 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 294 | 20 % PEG 3350, 1.5 % 1.6-DIAMINOHEXANE, 200 MM AMMONIUM CITRATE PH 7.0, 10 MM ZNSO4, 8 MM N-OXALYLGLYCINE, 4 MM INHIBITOR, PROTEIN 6.5 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K, TIME 2-7 DAYS |